FOIA Number: MULTI-HHS-20-0397

The Federal Government’s Latest Attempt to Delay the Release of Coronavirus Documents

June 23, 2020
Federal agencies have indicated they are attempting to delay the release of records related to White House efforts to control information — for up to two years.

Joint Status Report: American Oversight v. HHS, FDA, NIAID, CMS – Coronavirus Communications Directives

June 22, 2020
Joint Status Report filed by American Oversight and the Department of Health and Human Services, the Food and Drug Administration, the National Institute of Allergy and Infectious Diseases, and the Centers for Medicare and Medicaid Services in American Oversight’s lawsuit seeking email communications between agency and White House officials involved in the federal government’s coronavirus response, and any directives, orders, or guidance from HHS or the White House regarding public communications or press strategy.

An Update on American Oversight’s Coronavirus Investigation: New Lawsuits and Requests

April 23, 2020
With three lawsuits and more than 400 public records requests filed, American Oversight intends to get to the bottom of what has been happening behind the scenes in the Trump administration’s mismanaged pandemic response.
(Photo: Shutterstock)

Complaint: American Oversight v. HHS, FDA, NIAID, CMS – Coronavirus Communications Directives

April 23, 2020
American Oversight's lawsuit against the Department of Health and Human Services, the Food and Drug Administration, the National Institute of Allergy and Infectious Diseases, and the Centers for Medicare and Medicaid Services for email communications between agency and White House officials involved in the federal government’s coronavirus response, and any directives, orders, or guidance from HHS or the White House regarding public communications or press strategy.

FOIA to Multiple Agencies Seeking Coronavirus Messaging Directives

March 2, 2020
FOIA to multiple agencies seeking any directives, orders, decision memoranda, or guidance from the White House regarding public statements, public appearances, or communications or press strategy on the coronavirus, COVID-19.